Group A | Group B | |
---|---|---|
Symptoms score (NIH-CPSI questionnaire 0–43) (±S.D.) | ||
Baseline | 21.85 ± 5.23 | 22.56 ± 5.78 |
2 months | 12.00 ± 4.34 | 5.23 ± 2.76 |
4 months | 10.48 ± 4.14 | 4.11 ± 2.32 |
6 months | 13.26 ± 4.88 | 3.67 ± 1.98 |
Pain score (NIH-CPSI questionnaire 0–21) (±S.D.) | ||
Baseline | 11.65 ± 3.23 | 12.00 ± 2.78 |
2 months | 6.20 ± 2.35 | 2.13 ± 1.90 |
4 months | 5.82 ± 2.10 | 1.65 ± 1.17 |
6 months | 8.06 ± 2.81 | 1.25 ± 0.99 |
Urinary score (NIH-CPSI questionnaire 0–10) (±S.D.) | ||
Baseline | 4.65 ± 2.11 | 4.26 ± 2.28 |
2 months | 2.35 ± 1.35 | 1.34 ± 0.89 |
4 months | 2.10 ± 1.15 | 1.11 ± 0.89 |
6 months | 2.65 ± 1.44 | 1.01 ± 0.76 |
Symptoms (%) | ||
Baseline | 76 (100) | 77 (100) |
2 months | 15 (19.7) | 7 (9) |
4 months | 18 (23.7) | 7 (9) |
6 months | 20 (26.3) | 5 (6.5) |
QoL (NIH-CPSI questionnaire 0–12) (±S.D.) | ||
Baseline | 5.76 ± 2.44 | 5.66 ± 2.39 |
2 months | 2.89 ± 1.68 | 1.85 ± 1.00 |
4 months | 2.60 ± 1.43 | 1.66 ± 0.95 |
6 months | 3.09 ± 1.74 | 1.40 ± 0.94 |